Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Terminated1
Other1

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT04166734Phase 1Terminated
Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma
Advanced Malignant Pleural Mesothelioma
StudychairStart date: 2021-02-12
NCT02417662Not ApplicableActive Not Recruiting
Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
PrincipalinvestigatorStart date: 2016-08-19

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Royal Marsden NHS Foundation Trust

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04166734Phase 1StudyChair

Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma

Advanced Malignant Pleural Mesothelioma
Terminated
NCT02417662Not ApplicablePrincipalInvestigator

Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer

Non-small Cell Lung Cancer
Active Not Recruiting

All 2 trials loaded